Glutamine and Sport: Gut, Recovery and Immunity — What the Evidence Shows

L-glutamine is an amino acid produced by the body and found in food. The gut and certain immune cells use it, which explains its appeal in sports nutrition. The logical leap begins when this biological role gets turned into a promise: better immunity, faster recovery, a protected gut, improved performance. Trials don't support a general recommendation for all athletes.

Glutamine is involved in nitrogen transport and serves as a substrate for several tissues. The intestinal lining consumes some of it. Immune cells also use it as a metabolic fuel. These functions make it plausible that extra intake could help when exercise creates significant strain.

Plausible doesn't mean demonstrated. The body tightly regulates the availability of this amino acid. A transient drop in plasma glutamine after prolonged exercise has been observed in some studies, without proving that it causes more infections, poor recovery, or digestive problems. A marker is not a symptom, and a correlation is not a cause.

The real question isn't "does glutamine do anything?" It's more precise: in which population, after what kind of effort, at what dose, for how long, and measured against which actual outcome?

During intense endurance exercise, especially in significant heat, blood flow to the digestive system can decrease in favor of the muscles and thermoregulation. Motility, absorption, and digestive tolerance can all change. Researchers sometimes track these phenomena with permeability tests or markers like I-FABP. These tools serve research; on their own, they don't establish a diagnosis of "leaky gut."

In a crossover trial published in 2017, ten physically active men completed four tests: a placebo, then three glutamine doses corresponding to 0.25, 0.5, and 0.9 g/kg of lean mass. Each test involved 60 minutes of running at 70% of VO2max in a chamber heated to 30°C, with the dose taken two hours beforehand. The lactulose/rhamnose ratio, a permeability marker, was lower with glutamine than with placebo. Digestive symptoms were infrequent and were not improved.

This result is interesting, but narrow. Ten men, one lab, one temperature, one duration, one specific protocol: it doesn't allow us to infer general digestive protection. It doesn't show that glutamine prevents diarrhea, nausea, or dropping out of a race.

Later studies complicated the picture. In an 80-minute effort under sub-clinical heat stress, 0.3 g/kg of lean mass didn't protect permeability, markers of epithelial damage, or bacterial translocation. Another trial, with high-intensity running to exhaustion at 40°C, observed higher permeability under glutamine than under placebo, with no improvement in symptoms or other markers. These results don't prove a typical adverse effect; they mainly show that the effect isn't robust.

A 2024 meta-analysis pooled ten studies and 352 adults on intestinal permeability. The overall effect was not statistically significant. One subgroup suggested a signal at doses above 30 g/day over a short period, in varied health profiles and protocols not specific to sport. That is not a sports dosage.

Commercial claims often link glutamine with muscle repair, reduced soreness, and preserved strength. A small 2011 study in fifteen physically active men reported less loss of force and less soreness after one hundred drop jumps, with glutamine taken alongside a carbohydrate drink for four days. This eccentric-exercise model is very specific and doesn't demonstrate a benefit after every running or strength-training session.

Other studies have tracked creatine kinase, myoglobin, or cortisol. These markers describe a physiological response; they should not be confused with functional recovery, better training quality, or competitive performance. Studies also differ depending on whether glutamine is taken alone or in a blend with carbohydrates or amino acids.

The 2019 systematic review and meta-analysis included 47 studies in the systematic review, of which 25 trials went into the quantitative analyses. It found no general association between glutamine and aerobic capacity, body composition, or several markers of immune function. Results for certain anaerobic efforts and strength remained inconclusive.

The most solid levers remain more ordinary ones: adequate energy intake, carbohydrates matched to load and duration, sufficient protein spread across the day, hydration, sleep, and sensible progression.

The immunity argument rests on two facts: immune cells use glutamine, and certain prolonged efforts can change its plasma concentration. Gleeson's review points out that no direct evidence demonstrates a causal link between a post-exercise drop in plasma glutamine, impaired immunity, and more frequent infections in athletes.

The 2019 meta-analysis found no general effect on white blood cell, lymphocyte, or neutrophil counts. A small three-week trial in 21 boxers and taekwondo practitioners reported changes in salivary markers and self-reported respiratory infections. That's a signal, not proof of prevention: a small sample, a specific population, a short duration, and self-reported symptoms.

The cautious conclusion, then, is simple: the data are insufficient to say that glutamine protects against colds, flu, or training-related infections. It doesn't treat an infection and doesn't replace vaccination, sleep, diet, or medical advice.

There is no established universal sports protocol. Trials have used acute or repeated doses, amounts scaled to body weight or lean mass, and timing around one to two hours before exercise. A research dose doesn't become a personal recommendation.

The dosing literature reports that acute doses of roughly 20 to 30 g have been studied in healthy adults, and that one sports trial used about 28 g/day for 14 days. These figures describe a research exposure and tolerance within a group, not a requirement. High doses can cause nausea, bloating, vomiting, or diarrhea in some protocols.

If a healthy adult is considering a personal trial, caution means changing only one variable, testing well away from competition, following the label, and stopping if symptoms occur. A product certified by a third-party testing body can reduce, without eliminating, the contamination risk specific to sports supplements.

Start by defining the measurable problem. Digestive discomfort during a race can depend on heat, intensity, hydration, carbohydrate concentration, fiber intake before the start, or insufficient gut training. Soreness can come from an unusual load. Persistent fatigue may call for examining sleep, intake, recovery, and general health.

Next, look at the actual outcome studied. "Reduces a permeability marker in ten men in a lab" is not the same as "improves comfort for all runners." "Changes an immune marker" is not the same as "prevents an infection."

If diet, sleep, and training load are already consistent, a personal trial remains an individual decision with uncertain benefit. It shouldn't be introduced right before an important goal, nor should it mask a symptom that deserves a diagnosis.